Washington Trust Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.7K Buy
760
+160
+27% +$14K 0.01% 329
2026
Q1
$51.1K Hold
600
﹤0.01% 354
2025
Q4
$47.4K Sell
600
-752
-56% -$59K ﹤0.01% 358
2025
Q3
$108K Hold
1,352
0.01% 277
2025
Q2
$123K Hold
1,352
0.01% 240
2025
Q1
$127K Hold
1,352
0.01% 233
2024
Q4
$123K Hold
1,352
0.01% 234
2024
Q3
$140K Hold
1,352
0.01% 232
2024
Q2
$131K Hold
1,352
0.01% 230
2024
Q1
$122K Hold
1,352
0.01% 232
2023
Q4
$108K Hold
1,352
0.01% 240
2023
Q3
$96.1K Hold
1,352
0.01% 241
2023
Q2
$104K Hold
1,352
0.01% 234
2023
Q1
$102K Hold
1,352
0.01% 244
2022
Q4
$107K Hold
1,352
0.01% 242
2022
Q3
$95K Hold
1,352
0.01% 286
2022
Q2
$108K Sell
1,352
-446
-25% -$34.9K 0.01% 276
2022
Q1
$136K Sell
1,798
-1,011
-36% -$80.1K 0.01% 296
2021
Q4
$239K Buy
+2,809
New +$219K 0.02% 229

Other funds holding CL

Washington Trust Advisors's CL Position: Q2 2026 in Review

Washington Trust Advisors increased its Colgate-Palmolive (CL) stake by 27% in Q2 2026, buying an estimated $14K and bringing the position to 760 shares worth $69.7K. The position accounts for 0.01% of the portfolio, ranked #329.

Washington Trust Advisors first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $239K in Q4 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Washington Trust Advisors held 760 shares of Colgate-Palmolive worth $69.7K as of Q2 2026.
  • Washington Trust Advisors bought 160 Colgate-Palmolive shares in Q2 2026, an estimated $14K.
  • Colgate-Palmolive made up 0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #329 holding.
  • Washington Trust Advisors first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Colgate-Palmolive position peaked at $239K in Q4 2021.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.